Nectar Lifesciences informs about standalone financial results

23 Aug 2016 Evaluate

Nectar Lifesciences has informed about Standalone Financial Results, Limited Review for the period ended June 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

12.19 0.00 (0.00%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×